Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3 Trials

Main Article Content

Leon Kircik
Linda Stein Gold
James Del Rosso
Seemal Desai
Brad Glick
Howard Sofen
Anna Tallman
David Rubenstein
Philip Brown

Keywords

psoriasis, tapinarof, phase 3 trial

Abstract

N/A

References

1. Lebwohl M, et al. Skin. 2020;4(6):s75. https://doi.org/10.25251/skin.4.supp.75;

2. Strober B, et al. Innovations in Dermatology Virtual Spring Conference 2021, Poster Presentation, March 16–20, 2021.

Most read articles by the same author(s)

<< < 5 6 7 8 9 10